Urinary collagen crosslinks reflect further bone loss of femoral neck in osteoporotic patients undergoing vitamin D therapy

Endocrine Research

Volumn 24, Issue 2, 1998, Pages 259-267

  Ohishi, T ^a   Takahashi, M ^a   Kushida, K ^a   Yamazaki, K ^a   Hoshino, H ^a   Kitazawa, A ^a   Inoue, T ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BIOCHEMICAL MARKER; COLLAGEN DERIVATIVE; DEOXYPYRIDINOLINE; HYDROXYPROLINE; PYRIDINOLINE; VITAMIN D;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE MINERALIZATION; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; HYDROXYPROLINE URINE LEVEL; LUMBAR SPINE; MENOPAUSE; METABOLIC BONE DISEASE; ORAL DRUG ADMINISTRATION; OSTEOLYSIS; OSTEOMETRY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; VITAMIN INTAKE;

EID: 0031752101     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1080/07435809809135533     Document Type: Article

References (19)

1. Ohishi T, Takahashi M, Kushida K, Horiuchi K, Ishigaki S, Inoue T. 1992 Quantitative analyses of urinary pyridinoline and deoxypyridinoline in patients with hyperthyroidism. Endocrine Res. 18:281-290.
2. Seibel MJ, Gartenberg F, Silverberg SJ, Ratcliffe A, Robins SP, Bilezikian JP. 1992 Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 74:481-486.
3. Robins SP, Black D, Paterson DR, Reid DM, Duncan A, Seibel MJ. 1991 Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases. Eur. J. Clin. Invest. 21:310-315.
4. Sano M, Kushida K, Takahashi M, Ohishi T, Kawana K, Okada M, Inoue T. 1994 Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone metastasis. Br. J. Cancer 70:701-703.
5. Lipton A, Demers L, Daniloff Y, Curley E, Hamilton C, Harvey H, Witters L, Seaman J, Van der Giessen R, Seyedin S. 1993 Increased urinary excretion of pyridinium cross-links in cancer patients. Clin. Chem. 39:614-618.
6. Ohishi T, Kushida K, Takahashi M, Kawana K, Yagi K, Kawakami K, Horiuchi K, Inoue T. 1994 Urinary bone resorption markers in patients with metabolic bone disorders. Bone 15:15-20.
7. Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD. 1991 Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J. Clin. Endocrinol. Metab. 72:367-373.
8. Fledelius C, Riis BJ, Overgaad K, Christiansen C. 1994 The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis. Calcif. Tissue Int. 54:381-384.
9. Mole PA, Walkinshaw MH, Robins SP, Paterson CR. 1992 Can urinary pyridinium crosslinks and urinary oestrogens predict bone mass and rate of bone loss after the menopause? Eur. J. Clin. Invest. 22:767-771.
10. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. 1995 Applications of an enzyme immunoassay for a new marker of bone resorption (crosslaps): follow-up on hormone replacement therapy and osteoporosis risk assessment. J. Clin. Endocrinol. Metab. 80:864-868.
11. Garnero P, Hausherr E, Chapuy M-C, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD. 1996 Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J. Bone Miner. Res. 11:1531-1538.
12. Takahashi M, Ohishi T, Aoshima H, Kushida K, Inoue T, Horiuchi K. 1993 Pre-fractionation with cation exchanger for determination of intermolecular crosslinks, pyridinoline and pentosidine, in hydrolysate. J. Liq. Chromatogr. 16:1355-1370.
13. Kivirikko KI, Laitinen O, Prockop DJ. 1967 Modifications of a specific assay for hydroxyproline in urine. Anal. Biochem. 19:249-255.
14. Kin K, Kushida K, Yamazaki K, Okamoto S, Inoue T. 1991 Bone mineral density of the spine in normal Japanese subjects using dual-energy x-ray absorptiometry: Effect of obesity and menopausal status. Calcif. Tissue Int. 49:101-106.
15. Dresner-Pollak R, Parker RA, Poku M, Thompson J, Seibel MJ, Greenspan SL. 1996 Biochemical markers of bone turnover reflect femoral bone loss in erderly women. Calcif. Tissue Int. 59:328-333.
16. Cosman F, Nieves J, Wilkinson C, Schnering D, Shen V, Lindsay R. 1996Bone density change and biochemical indices of skeletal turnover. Calcif. Tissue Int. 58:236-243.
17. Eyre DR, Koob TJ, Van Ness KP. 1984 Quantitation of hydroxypyridinium crosslinks in collagen by high performance liquid chromatography. Anal. Biochem. 137:380-388.
18. Steiger P, Cummings SR, Black DM, Spencer NE, Genant HK. 1992 Age-related decrements in bone mineral density in women over 65. J. Bone Miner. Res. 7:625-632.
19. 3 on lumbar bone mineral density and vertebral fracture in patients with postmenopausal osteoporosis. Calcif. Tissue Int. 54:370-376.